A traumatic brain injury (TBI) is a major health issue affecting many people across the world,
causing significant morbidity and mortality. TBIs often have long-lasting effects, disrupting …

Traumatic brain injury (TBI) is a leading cause of long-term disability across the world.
Evidence for the usefulness of imaging and fluid biomarkers to predict outcomes and screen …

Rodent models are important research tools for studying the pathophysiology of traumatic
brain injury (TBI) and developing new therapeutic interventions for this devastating …

INTRODUCTION Rapidly progressive dementias (RPDs) are a group of neurological
disorders characterized by a rapid cognitive decline. The diagnostic value of blood‐based …

Aging presents progressive changes that increase the susceptibility of the central nervous
system (CNS) to suffer neurological disorders (NDs). Several studies have reported that an …

Purpose We studied the promising Alzheimer biomarker plasma tau phosphorylated at
threonine 231 (p-tau231) in a cohort of cardiac arrest patients who survived to intensive care …

Background A blood‐based biomarker that accurately reflects neuronal injury in acute
ischemic stroke could be an easily accessible and cost‐effective complement to clinical and …

Objectives To investigate whether circulating acute-phase brain-derived tau (BD-tau) is
associated with functional outcome after ischemic stroke. Methods Plasma tau was …

The evolution of infarcts varies widely among patients with acute ischemic stroke (IS) and
influences treatment decisions. Neuroimaging is not applicable for frequent monitoring and …

Objective: Current methods for early detection of hypoxic–ischemic encephalopathy (HIE)
are limited by lack of specificity, cost, and time constraints. Blood tau protein concentrations …